Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SNGX Soligenix, Inc.

交易中 07-22 11:57:26 EDT

5.21

-0.86

-14.17%

最高6.15	最低5.16	成交量14.43万
今开5.99	昨收6.07	日振幅16.31%
总市值514.48万	流通市值513.31万	总股本98.75万
成交额80.34万	换手率14.64%	流通股本98.52万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SNGX","market":"US","secType":"STK","nameCN":"Soligenix, Inc.","latestPrice":5.21,"timestamp":1721663767354,"preClose":6.07,"halted":0,"volume":144286,"delay":0,"floatShares":985245,"shares":987489,"eps":-11.611141,"marketStatus":"交易中","marketStatusCode":2,"change":-0.86,"latestTime":"07-22 11:57:26 EDT","open":5.99,"high":6.15,"low":5.16,"amount":803428.383087,"amplitude":0.163097,"askPrice":5.39,"askSize":4649,"bidPrice":5.23,"bidSize":269,"shortable":0,"etf":0,"ttmEps":-11.611141,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"adjPreClose":6.07,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.08,"preClose":6.07,"latestTime":"09:29 EDT","volume":3798,"amount":23066.733321,"timestamp":1721654947928},"postHourTrading":{"tag":"盘后","latestPrice":5.97,"preClose":6.07,"latestTime":"19:59 EDT","volume":2497,"amount":14896.3202,"timestamp":1721433568757},"volumeRatio":0.803686},"requestUrl":"/m/hq/s/SNGX","defaultTab":"news","newsList":[{"id":"2453952337","title":"Soligenix, Inc.盘中异动 早盘股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453952337","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453952337?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:59","pubTimestamp":1721656751,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时59分，Soligenix, Inc.股票出现波动，股价急速跳水5.60%。截至发稿，该股报5.73美元/股，成交量2.4631万股，换手率2.49%，振幅5.60%。Soligenix, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722215911af9372d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722215911af9372d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2450044190","title":"BUZZ-癌症治疗晚期试验中期数据良好，Soligenix 公司业绩大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2450044190","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450044190?lang=zh_cn&edition=full","pubTime":"2024-07-09 20:51","pubTimestamp":1720529463,"startTime":"0","endTime":"0","summary":"    7月9日 - ** 药物开发商 Soligenix   股价盘前大涨 211% 至 6.22 美元** 该公司报告了 ，其基于光的实验性疗法HyBryte治疗早期皮肤T细胞淋巴瘤患者的后期试验中期数据呈阳性** 皮肤 T 细胞淋巴瘤是一种罕见的癌症，起病于某些白细胞，可引起皮肤发红或鳞屑性斑块。** SNGX公司说，迄今为止，已有6名患者接受了HyBryte治疗，治疗时间长达44周。** 该公司称，在完成至少 12 周治疗的 4 名患者中，有 3 人获得了 \"治疗成功\"。** 截至上一交易日收盘，股价累计下跌 83.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139","BUZZ"],"gpt_icon":0},{"id":"2439998463","title":"Soligenix Inc-打算对其普通股进行反向分割拆分后每16股分拆前股票的比例为1股","url":"https://stock-news.laohu8.com/highlight/detail?id=2439998463","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439998463?lang=zh_cn&edition=full","pubTime":"2024-05-31 19:36","pubTimestamp":1717155418,"startTime":"0","endTime":"0","summary":"Soligenix Inc-打算对其普通股进行反向分割拆分后每16股分拆前股票的比例为1股","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531193704957f6841&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531193704957f6841&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2435322497","title":"Soligenix Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435322497","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435322497?lang=zh_cn&edition=full","pubTime":"2024-05-13 20:32","pubTimestamp":1715603522,"startTime":"0","endTime":"0","summary":"   * Soligenix Inc   报告了截至1月底的季度调整后每股亏损18美分，高于去年同期的每股-36美分。两位分析师对该季度的平均预期是每股亏损 19 美分。* 营收同比下降 61%，为 11.703 万美元；分析师预期为 20 万美元。* Soligenix Inc 公布的本季度每股收益为亏损 18 美分。* 该公司当季亏损 192 万美元。* Soligenix Inc 本季度股价下跌了 33.5%，今年迄今为止下跌了 47.3%。华尔街对 Soligenix Inc 的 12 个月目标价中位数为 3.50 美元。本摘要由 LSEG 数据于世界协调时 5 月 13 日中午 12:31 自动生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2434185388","title":"Soligenix Inc    预计每股亏损 19 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434185388","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434185388?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:14","pubTimestamp":1715343279,"startTime":"0","endTime":"0","summary":"   * ) Soligenix公司   预计在5月13日公布截至2024年3月31日的业绩时，(，季度收入将出现下降。* LSEG 分析师对 Soligenix 公司的平均预期是每股亏损 19 美分。* 一位分析师对该公司股票的评级为 \"买入\"。* 华尔街对 Soligenix Inc 的 12 个月目标价中位数为 3.50 美元，高于上一次 0.41 美元的收盘价。5月10日 - 本摘要于北京时间 5 月 10 日 12:14 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.soligenix.com","stockEarnings":[{"period":"1week","weight":-0.183},{"period":"1month","weight":0.4316},{"period":"3month","weight":-0.1198},{"period":"6month","weight":-0.3388},{"period":"1year","weight":-0.433},{"period":"ytd","weight":-0.499}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Soligenix, Inc.是一家临床阶段生物制药公司，成立于1987年，专注于开发产品，治疗癌症和严重的胃肠道疾病的治疗所产生的危及生命的副作用（仍然是一个未满足的医疗需求），以及开发多种生物防御疫苗和疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.130569},{"month":2,"riseRate":0.625,"avgChangeRate":-0.04077},{"month":3,"riseRate":0.25,"avgChangeRate":-0.095252},{"month":4,"riseRate":0.125,"avgChangeRate":-0.149397},{"month":5,"riseRate":0.25,"avgChangeRate":-0.127977},{"month":6,"riseRate":0.5,"avgChangeRate":-0.097746},{"month":7,"riseRate":0.75,"avgChangeRate":0.356281},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.062705},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.01391},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.031066},{"month":11,"riseRate":0.571429,"avgChangeRate":0.165289},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.112298}],"exchange":"NASDAQ","name":"Soligenix, Inc.","nameEN":"Soligenix, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Soligenix, Inc.(SNGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Soligenix, Inc.,SNGX,Soligenix, Inc.股票,Soligenix, Inc.股票老虎,Soligenix, Inc.股票老虎国际,Soligenix, Inc.行情,Soligenix, Inc.股票行情,Soligenix, Inc.股价,Soligenix, Inc.股市,Soligenix, Inc.股票价格,Soligenix, Inc.股票交易,Soligenix, Inc.股票购买,Soligenix, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Soligenix, Inc.(SNGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}